British Journal of Ophthalmology 1986;70:844-851; doi:10.1136/bjo.70.11.844
Copyright © 1986 by the BMJ Publishing Group Ltd.
Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years' experience.
P K Lommatzsch
From 1964 to 1984 309 patients with choroidal melanoma were treated with 106Ru/106Rh beta ray applicators (1000 Gy at the apex of the tumour within 7-14 days). In cases 216 (69.9%) this treatment was successful for a mean follow-up period of 6.7 years after irradiation. In 53 cases (17.2%) the eye had to be enucleated, and 40 patients (12.9%) died from metastases within this period. Of the 216 successfully treated patients 114 (52.8%) developed flat scars and 49 (22.7%) retained a visual acuity of 1.5-0.5. Radiogenic late complications with damage to the retinal capillary system were the main causes of visual deterioration, especially in eyes with tumours close to the posterior pole. The survival rate is substantially higher than that for patients whose eyes were primarily enucleated. beta Ray applicators with 106Ru/106Rh can be recommended as an effective tool and a simple and cheap procedure to cure patients with small and medium sized choroidal melanomas. They save the eye without endangering our patients' lives.
This article has been cited by other articles:

|
 |

|
 |
 
R van Ginderdeuren, E van Limbergen, and W Spileers
18 Years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma
Br. J. Ophthalmol.,
October 1, 2005;
89(10):
1306 - 1310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Rem, J. A. Oosterhuis, H. G. Journee-de Korver, D. de Wolff-Rouendaal, and J. E. E. Keunen
Transscleral Thermotherapy: Short- and Long-term Effects of Transscleral Conductive Heating in Rabbit Eyes
Arch Ophthalmol,
April 1, 2003;
121(4):
510 - 516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pe'er, F. H Stefani, S. Seregard, T. Kivela, P. Lommatzsch, J. U Prause, B. Sobottka, B. Damato, and I. Chowers
Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study
Br. J. Ophthalmol.,
October 1, 2001;
85(10):
1208 - 1212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Shields, J. A. Shields, J. Cater, K. Gunduz, C. Miyamoto, B. Micaily, and L. W. Brady
Plaque Radiotherapy for Uveal Melanoma: Long-term Visual Outcome in 1106 Consecutive Patients
Arch Ophthalmol,
September 1, 2000;
118(9):
1219 - 1228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Gunduz, C. L. Shields, J. A. Shields, J. Cater, J. E. Freire, and L. W. Brady
Plaque Radiotherapy of Uveal Melanoma With Predominant Ciliary Body Involvement
Arch Ophthalmol,
February 1, 1999;
117(2):
170 - 177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T. Finger, R. Iezzi, J. M. Romero, R. B. Rosen, A. Szechter, and H. Hegde
Plaque-Mounted Diode-Light Transillumination for Localization Around Intraocular Tumors
Arch Ophthalmol,
February 1, 1999;
117(2):
179 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J Kertes, J. C Johnson, and G. A Peyman
Internal resection of posterior uveal melanomas
Br. J. Ophthalmol.,
October 1, 1998;
82(10):
1147 - 1153.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. T. Finger, J. M. Romero, R. B. Rosen, R. Iezzi, R. Emery, and A. Berson
Three-dimensional Ultrasonography of Choroidal Melanoma: Localization of Radioactive Eye Plaques
Arch Ophthalmol,
March 1, 1998;
116(3):
305 - 312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Müllner, G Langmann, G Pendl, and J Faulborn
Echographic findings in uveal melanomas treated with the Leksell gamma knife
Br. J. Ophthalmol.,
February 1, 1998;
82(2):
154 - 158.
[Abstract]
[Full Text]
|
 |
|
|
|